| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.927 | 0.001 | 0.927 | GABA C receptor agonist | 0.838 0.001 CHEMBL1157 | ||
| 0.915 | 0.001 | 0.915 | Glutamate decarboxylase inhibitor | 0.777 0.002 CHEMBL1157 | ||
| 0.804 | 0.003 | 0.821 | Alcohol oxidase inhibitor | 0.821 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.747 | 0.002 | 0.763 | Porphobilinogen synthase inhibitor | 0.763 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.746 | 0.005 | 0.864 | Platelet antagonist | 0.864 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.732 | 0.002 | 0.732 | Glutamate dehydrogenase inhibitor | 0.628 0.002 CHEMBL1157 | ||
| 0.706 | 0.004 | 0.706 | Superoxide dismutase inhibitor | 0.544 0.009 CHEMBL1157 | ||
| 0.653 | 0.003 | 0.653 | Phospholipase C inhibitor | 0.524 0.005 CHEMBL1157 | ||
| 0.651 | 0.002 | 0.651 | GABA aminotransferase inhibitor | 0.323 0.003 CHEMBL1157 | ||
| 0.674 | 0.027 | 0.761 | Caspase 9 stimulant | 0.761 0.016 CHEMBL1157 | CHEMBL1157 | |
| 0.639 | 0.003 | 0.639 | Growth hormone agonist | 0.593 0.004 CHEMBL1157 | ||
| 0.64 | 0.009 | 0.64 | Interleukin antagonist | 0.557 0.015 CHEMBL1157 | ||
| 0.604 | 0.016 | 0.604 | Antithrombotic | 0.57 0.019 CHEMBL1157 | ||
| 0.591 | 0.004 | 0.591 | Interleukin 2 agonist | 0.561 0.004 CHEMBL1157 | ||
| 0.602 | 0.018 | 0.689 | Cholesterol antagonist | 0.689 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.583 | 0.003 | 0.583 | 5 Hydroxytryptamine uptake stimulant | 0.573 0.003 CHEMBL1157 | ||
| 0.586 | 0.021 | 0.69 | Aldehyde oxidase inhibitor | 0.69 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.57 | 0.005 | 0.57 | Interleukin agonist | 0.495 0.009 CHEMBL1157 | ||
| 0.569 | 0.008 | 0.569 | Angiogenesis stimulant | 0.562 0.009 CHEMBL1157 | ||
| 0.571 | 0.013 | 0.653 | Apoptosis antagonist | 0.653 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.568 | 0.018 | 0.568 | 5 Hydroxytryptamine release stimulant | 0.559 0.019 CHEMBL1157 | ||
| 0.562 | 0.014 | 0.615 | Histamine release inhibitor | 0.615 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.547 | 0.008 | 0.547 | Psychostimulant | 0.445 0.016 CHEMBL1157 | ||
| 0.531 | 0.004 | 0.6 | Tyrosine 3 hydroxylase inhibitor | 0.6 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.522 | 0.003 | 0.752 | Succinate dehydrogenase inhibitor | 0.752 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.519 | 0.005 | 0.519 | Thrombolytic | 0.469 0.006 CHEMBL1157 | ||
| 0.514 | 0.005 | 0.782 | Alpha-N-acetylglucosaminidase inhibitor | 0.782 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.517 | 0.008 | 0.592 | Peroxidase inhibitor | 0.592 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.528 | 0.019 | 0.528 | Immunomodulator | 0.505 0.022 CHEMBL1157 | ||
| 0.505 | 0.002 | 0.505 | GABA C receptor antagonist | 0.333 0.004 CHEMBL1157 | ||
| 0.504 | 0.002 | 0.504 | Ornithine carbamoyltransferase inhibitor | 0.271 0.005 CHEMBL1157 | ||
| 0.517 | 0.021 | 0.565 | GABA C receptor rho-3 antagonist | 0.565 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.485 | 0.003 | 0.571 | Ferrochelatase inhibitor | 0.571 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.485 | 0.004 | 0.485 | Aldehyde dehydrogenase inhibitor | 0.449 0.005 CHEMBL1157 | ||
| 0.47 | 0.003 | 0.593 | Triose-phosphate isomerase inhibitor | 0.593 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.477 | 0.011 | 0.665 | Platelet aggregation inhibitor | 0.665 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.472 | 0.01 | 0.513 | Anesthetic general | 0.513 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.46 | 0.003 | 0.538 | Carbamoyl phosphate synthetase inhibitor | 0.538 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.485 | 0.031 | 0.485 | Immunostimulant | 0.418 0.045 CHEMBL1157 | ||
| 0.451 | 0.002 | 0.451 | NMDA receptor agonist | 0.275 0.003 CHEMBL1157 | ||
| 0.486 | 0.037 | 0.586 | 5 Hydroxytryptamine release inhibitor | 0.586 0.013 CHEMBL1157 | CHEMBL1157 | |
| 0.48 | 0.032 | 0.636 | Vasodilator, peripheral | 0.636 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.459 | 0.018 | 0.459 | DNA damaging | 0.354 0.04 CHEMBL1157 | ||
| 0.43 | 0.002 | 0.784 | Aconitate hydratase inhibitor | 0.784 0.001 CHEMBL1157 | CHEMBL1157 | |
| 0.43 | 0.004 | 0.43 | Histidine decarboxylase inhibitor | 0.359 0.005 CHEMBL1157 | ||
| 0.428 | 0.005 | 0.428 | Peptidyltransferase inhibitor | 0.286 0.03 CHEMBL1157 | ||
| 0.479 | 0.057 | 0.741 | Cyclophilin D inhibitor | 0.741 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.461 | 0.044 | 0.531 | Immunosuppressant | 0.531 0.025 CHEMBL1157 | CHEMBL1157 | |
| 0.417 | 0.003 | 0.432 | Adenylate kinase inhibitor | 0.432 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.431 | 0.017 | 0.431 | Insulysin inhibitor | 0.402 0.022 CHEMBL1157 | ||
| 0.416 | 0.015 | 0.416 | Anticoagulant | 0.34 0.023 CHEMBL1157 | ||
| 0.399 | 0.004 | 0.399 | Hematopoietic | 0.333 0.005 CHEMBL1157 | ||
| 0.388 | 0.002 | 0.388 | GABA C receptor rho-1 antagonist | 0.274 0.004 CHEMBL1157 | ||
| 0.386 | 0.003 | 0.386 | Phenylalanine 4-hydroxylase inhibitor | 0.363 0.003 CHEMBL1157 | ||
| 0.386 | 0.004 | 0.517 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.517 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.385 | 0.003 | 0.483 | Phosphofructokinase-1 inhibitor | 0.483 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.388 | 0.009 | 0.388 | Protein kinase stimulant | 0.368 0.01 CHEMBL1157 | ||
| 0.383 | 0.005 | 0.383 | Aminopeptidase B inhibitor | 0.291 0.009 CHEMBL1157 | ||
| 0.438 | 0.061 | 0.438 | Antibacterial | 0.376 0.088 CHEMBL1157 | ||
| 0.398 | 0.022 | 0.437 | DNA synthesis inhibitor | 0.437 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.392 | 0.019 | 0.457 | Sodium/bile acid cotransporter inhibitor | 0.457 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.395 | 0.028 | 0.58 | Hypoglycemic | 0.58 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.368 | 0.002 | 0.368 | GABA B receptor agonist | 0.253 0.003 CHEMBL1157 | ||
| 0.368 | 0.004 | 0.368 | Carbonic anhydrase III inhibitor | 0.292 0.006 CHEMBL1157 | ||
| 0.368 | 0.01 | 0.368 | Hemostatic | 0.246 0.022 CHEMBL1157 | ||
| 0.36 | 0.002 | 0.567 | Fumarate hydratase inhibitor | 0.567 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.343 | 0.004 | 0.343 | Toll-Like receptor 2 antagonist | 0.28 0.006 CHEMBL1157 | ||
| 0.342 | 0.01 | 0.342 | Alkylator | 0.253 0.016 CHEMBL1157 | ||
| 0.376 | 0.044 | 0.376 | Vasodilator, coronary | 0.37 0.046 CHEMBL1157 | ||
| 0.377 | 0.045 | 0.377 | Spasmolytic | 0.343 0.055 CHEMBL1157 | ||
| 0.344 | 0.012 | 0.409 | Gastrin inhibitor | 0.409 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.33 | 0.001 | 0.33 | Lysine carboxypeptidase inhibitor | 0.153 0.003 CHEMBL1157 | ||
| 0.339 | 0.013 | 0.415 | Bone formation stimulant | 0.415 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.329 | 0.004 | 0.356 | Photosensitizer | 0.356 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.364 | 0.041 | 0.404 | Calcium channel activator | 0.404 0.023 CHEMBL1157 | CHEMBL1157 | |
| 0.327 | 0.005 | 0.327 | Carbonic anhydrase VI inhibitor | 0.24 0.009 CHEMBL1157 | ||
| 0.332 | 0.011 | 0.336 | Insulin sensitizer | 0.336 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.323 | 0.005 | 0.419 | Catalase inhibitor | 0.419 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.323 | 0.005 | 0.372 | Alcohol dehydrogenase inhibitor | 0.372 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.319 | 0.004 | 0.329 | Argininosuccinate synthase inhibitor | 0.329 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.325 | 0.01 | 0.328 | Phospholipase A2 inhibitor | 0.328 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.317 | 0.003 | 0.317 | Ornithine decarboxylase inhibitor | 0.204 0.005 CHEMBL1157 | ||
| 0.323 | 0.009 | 0.323 | Chelator | 0.313 0.01 CHEMBL1157 | ||
| 0.329 | 0.018 | 0.329 | Diuretic | 0.304 0.022 CHEMBL1157 | ||
| 0.342 | 0.036 | 0.342 | Amyloid beta aggregation inhibitor | 0.195 0.081 CHEMBL1157 | ||
| 0.317 | 0.012 | 0.317 | Neurotensin receptor agonist | 0.271 0.018 CHEMBL1157 | ||
| 0.31 | 0.006 | 0.31 | Histone deacetylase SIRT1 inhibitor | 0.219 0.024 CHEMBL1157 | ||
| 0.329 | 0.025 | 0.393 | Platelet adhesion inhibitor | 0.393 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.304 | 0.003 | 0.304 | Adenylate cyclase stimulant | 0.273 0.003 CHEMBL1157 | ||
| 0.301 | 0.005 | 0.383 | GP IIb/IIIa receptor antagonist | 0.383 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.314 | 0.02 | 0.356 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.356 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.306 | 0.013 | 0.306 | Adenylate cyclase inhibitor | 0.235 0.021 CHEMBL1157 | ||
| 0.289 | 0.011 | 0.505 | Cell adhesion inhibitor | 0.505 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.32 | 0.042 | 0.401 | Vasodilator | 0.401 0.023 CHEMBL1157 | CHEMBL1157 | |
| 0.279 | 0.004 | 0.279 | NMDA 2C receptor antagonist | 0.138 0.008 CHEMBL1157 | ||
| 0.274 | 0.003 | 0.274 | Glycine receptor agonist | 0.25 0.003 CHEMBL1157 | ||
| 0.288 | 0.017 | 0.288 | Interleukin 6 antagonist | 0.259 0.021 CHEMBL1157 | ||
| 0.299 | 0.028 | 0.367 | Non-steroidal antiinflammatory agent | 0.367 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.291 | 0.023 | 0.407 | Lipocortins synthesis antagonist | 0.407 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.268 | 0.004 | 0.318 | Folate antagonist | 0.318 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.283 | 0.021 | 0.358 | Amylase inhibitor | 0.358 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.273 | 0.012 | 0.276 | Cell wall synthesis inhibitor | 0.276 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.341 | 0.08 | 0.38 | Transcription factor NF kappa B inhibitor | 0.38 0.068 CHEMBL1157 | CHEMBL1157 | |
| 0.269 | 0.011 | 0.292 | Expectorant | 0.292 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.262 | 0.004 | 0.348 | Biliverdin reductase inhibitor | 0.348 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.282 | 0.029 | 0.282 | Neuropeptide Y2 antagonist | 0.252 0.054 CHEMBL1157 | ||
| 0.27 | 0.016 | 0.531 | Insulin secretagoues | 0.531 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.261 | 0.009 | 0.261 | NMDA receptor antagonist | 0.142 0.027 CHEMBL1157 | ||
| 0.258 | 0.009 | 0.258 | Histone deacetylase class III inhibitor | 0.191 0.022 CHEMBL1157 | ||
| 0.282 | 0.034 | 0.34 | DNA methylase inhibitor | 0.34 0.019 CHEMBL1157 | CHEMBL1157 | |
| 0.254 | 0.006 | 0.261 | Mucolytic | 0.261 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.258 | 0.011 | 0.258 | Carbonic anhydrase XV inhibitor | 0.152 0.03 CHEMBL1157 | ||
| 0.25 | 0.004 | 0.25 | Interferon agonist | 0.193 0.006 CHEMBL1157 | ||
| 0.247 | 0.003 | 0.247 | AMPA 4 receptor antagonist | 0.131 0.004 CHEMBL1157 | ||
| 0.243 | 0.005 | 0.275 | Prolactin inhibitor | 0.275 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.243 | 0.004 | 0.243 | Glycine transporter 2 inhibitor | 0.125 0.01 CHEMBL1157 | ||
| 0.282 | 0.045 | 0.282 | Anticonvulsant | 0.221 0.069 CHEMBL1157 | ||
| 0.245 | 0.009 | 0.245 | Nav1.4 sodium channel blocker | 0.193 0.021 CHEMBL1157 | ||
| 0.286 | 0.053 | 0.552 | Hypolipemic | 0.552 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.256 | 0.023 | 0.256 | Antipruritic | 0.229 0.032 CHEMBL1157 | ||
| 0.238 | 0.006 | 0.238 | Vanilloid 1 agonist | 0.22 0.008 CHEMBL1157 | ||
| 0.238 | 0.007 | 0.238 | Interleukin 8 antagonist | 0.204 0.012 CHEMBL1157 | ||
| 0.287 | 0.056 | 0.287 | Antiamyloidogenic | 0.228 0.082 CHEMBL1157 | ||
| 0.237 | 0.005 | 0.585 | Integrin antagonist | 0.585 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.238 | 0.01 | 0.238 | Carbonic anhydrase XIII inhibitor | 0.211 0.013 CHEMBL1157 | ||
| 0.241 | 0.013 | 0.393 | Catenin beta inhibitor | 0.393 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.23 | 0.003 | 0.242 | Glutamate (mGluR3) antagonist | 0.242 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.322 | 0.097 | 0.528 | Toll-Like receptor agonist | 0.528 0.027 CHEMBL1157 | CHEMBL1157 | |
| 0.229 | 0.005 | 0.229 | Toll-Like receptor 2 agonist | 0.179 0.009 CHEMBL1157 | ||
| 0.263 | 0.04 | 0.341 | Hepatoprotectant | 0.341 0.02 CHEMBL1157 | CHEMBL1157 | |
| 0.224 | 0.004 | 0.245 | Acyl-CoA dehydrogenase inhibitor | 0.245 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.228 | 0.009 | 0.313 | NADH dehydrogenase inhibitor | 0.313 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.222 | 0.005 | 0.234 | Aminopeptidase I inhibitor | 0.234 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.284 | 0.068 | 0.404 | Antioxidant | 0.404 0.034 CHEMBL1157 | CHEMBL1157 | |
| 0.218 | 0.004 | 0.234 | Sphingosine 1-phosphate receptor 4 agonist | 0.234 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.221 | 0.009 | 0.221 | Aminoacyl-tRNA synthetase inhibitor | 0.121 0.03 CHEMBL1157 | ||
| 0.216 | 0.005 | 0.216 | Heat shock protein 70 antagonist | 0.201 0.006 CHEMBL1157 | ||
| 0.216 | 0.006 | 0.281 | Electrolyte absorption antagonist | 0.281 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.253 | 0.046 | 0.346 | DNA methyltransferase I inhibitor | 0.346 0.015 CHEMBL1157 | CHEMBL1157 | |
| 0.212 | 0.007 | 0.212 | Carbonic anhydrase stimulant | 0.14 0.012 CHEMBL1157 | ||
| 0.221 | 0.017 | 0.26 | Arachidonic acid antagonist | 0.26 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.206 | 0.003 | 0.337 | Glutamate (mGluR6) antagonist | 0.337 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.21 | 0.007 | 0.21 | Inducible nitric-oxide synthase inhibitor | 0.118 0.026 CHEMBL1157 | ||
| 0.216 | 0.014 | 0.218 | Cyclooxygenase 3 inhibitor | 0.218 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.25 | 0.049 | 0.367 | RNA-directed DNA polymerase inhibitor | 0.367 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.222 | 0.022 | 0.351 | DNA polymerase I inhibitor | 0.351 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.217 | 0.021 | 0.365 | Cystathionine beta-synthase inhibitor | 0.365 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.2 | 0.005 | 0.206 | Glutamate release inhibitor | 0.206 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.202 | 0.007 | 0.202 | Neurotensin receptor antagonist | 0.068 0.021 CHEMBL1157 | ||
| 0.202 | 0.007 | 0.221 | Sphingosine 1-phosphate receptor 2 antagonist | 0.221 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.203 | 0.009 | 0.203 | Nitric-oxide synthase inhibitor | 0.114 0.042 CHEMBL1157 | ||
| 0.197 | 0.003 | 0.197 | AMPA 3 receptor antagonist | 0.075 0.005 CHEMBL1157 | ||
| 0.268 | 0.075 | 0.268 | Transcription factor STAT inhibitor | 0.235 0.098 CHEMBL1157 | ||
| 0.197 | 0.005 | 0.197 | NMDA 2A receptor antagonist | 0.101 0.013 CHEMBL1157 | ||
| 0.346 | 0.155 | 0.445 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.445 0.065 CHEMBL1157 | CHEMBL1157 | |
| 0.199 | 0.011 | 0.27 | Creatine kinase inhibitor | 0.27 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.206 | 0.021 | 0.207 | Cathepsin H inhibitor | 0.207 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.22 | 0.035 | 0.348 | Interferon gamma antagonist | 0.348 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.187 | 0.002 | 0.187 | Arginase inhibitor | 0.127 0.003 CHEMBL1157 | ||
| 0.196 | 0.013 | 0.212 | Sphingosine 1-phosphate receptor 5 antagonist | 0.212 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.186 | 0.005 | 0.225 | Ca2+-transporting ATPase inhibitor | 0.225 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.183 | 0.004 | 0.183 | GABA B receptor antagonist | 0.1 0.005 CHEMBL1157 | ||
| 0.18 | 0.003 | 0.18 | Mannosidase inhibitor | 0.168 0.004 CHEMBL1157 | ||
| 0.207 | 0.03 | 0.207 | Death-associated protein kinase 2 inhibitor | |||
| 0.202 | 0.028 | 0.248 | GABA C receptor rho-2 antagonist | 0.248 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.191 | 0.016 | 0.191 | Mediator release inhibitor | 0.191 0.016 CHEMBL1157 | ||
| 0.191 | 0.017 | 0.209 | Cathepsin G inhibitor | 0.209 0.015 CHEMBL1157 | CHEMBL1157 | |
| 0.245 | 0.071 | 0.352 | Free radical scavenger | 0.352 0.038 CHEMBL1157 | CHEMBL1157 | |
| 0.186 | 0.013 | 0.229 | Selectin antagonist | 0.229 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.187 | 0.014 | 0.238 | HIV-1 integrase (Overall Integration) inhibitor | 0.238 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.178 | 0.006 | 0.178 | Carbonic anhydrase VB inhibitor | 0.146 0.009 CHEMBL1157 | ||
| 0.178 | 0.009 | 0.178 | Somatostatin 1 agonist | |||
| 0.206 | 0.037 | 0.206 | Thiol protease inhibitor | 0.198 0.04 CHEMBL1157 | ||
| 0.172 | 0.005 | 0.423 | Sphingosine 1-phosphate receptor 5 agonist | 0.423 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.205 | 0.039 | 0.269 | Melanin inhibitor | 0.269 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.223 | 0.057 | 0.26 | Nitric-oxide synthase stimulant | 0.26 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.177 | 0.012 | 0.177 | CXC chemokine 4 receptor antagonist | |||
| 0.168 | 0.004 | 0.168 | AMPA 1 receptor antagonist | 0.082 0.007 CHEMBL1157 | ||
| 0.173 | 0.01 | 0.19 | Interleukin 1 beta converting enzyme inhibitor | 0.19 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.167 | 0.004 | 0.167 | Kainate receptor antagonist | 0.123 0.005 CHEMBL1157 | ||
| 0.172 | 0.012 | 0.486 | Cell adhesion molecule inhibitor | 0.486 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.171 | 0.011 | 0.171 | Antimetabolite | 0.152 0.012 CHEMBL1157 | ||
| 0.172 | 0.013 | 0.222 | DOPA decarboxylase inhibitor | 0.222 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.338 | 0.182 | 0.616 | Antiinflammatory | 0.616 0.049 CHEMBL1157 | CHEMBL1157 | |
| 0.167 | 0.011 | 0.167 | Carbonic anhydrase V inhibitor | 0.15 0.014 CHEMBL1157 | ||
| 0.162 | 0.008 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.168 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.157 | 0.004 | 0.157 | Glutamate (mGluR4) antagonist | 0.148 0.004 CHEMBL1157 | ||
| 0.157 | 0.005 | 0.157 | Sirtuin 1 inhibitor | 0.105 0.02 CHEMBL1157 | ||
| 0.161 | 0.011 | 0.161 | Histamine N-methyltransferase inhibitor | 0.126 0.026 CHEMBL1157 | ||
| 0.152 | 0.005 | 0.152 | Interferon inducer | 0.125 0.007 CHEMBL1157 | ||
| 0.16 | 0.014 | 0.16 | Factor V inhibitor | 0.141 0.023 CHEMBL1157 | ||
| 0.192 | 0.046 | 0.192 | Acetylcholine M1 receptor antagonist | 0.149 0.075 CHEMBL1157 | ||
| 0.154 | 0.009 | 0.468 | Prostaglandin EP2 antagonist | 0.468 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.15 | 0.006 | 0.15 | NMDA receptor subunit 3B antagonist | 0.14 0.007 CHEMBL1157 | ||
| 0.154 | 0.011 | 0.191 | Glutathione S-transferase inhibitor | 0.191 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.153 | 0.01 | 0.153 | Carbonic anhydrase VA inhibitor | 0.139 0.013 CHEMBL1157 | ||
| 0.237 | 0.094 | 0.239 | Transcription factor STAT3 inhibitor | 0.239 0.093 CHEMBL1157 | CHEMBL1157 | |
| 0.158 | 0.015 | 0.158 | NMDA 2 receptor antagonist | 0.085 0.04 CHEMBL1157 | ||
| 0.147 | 0.005 | 0.266 | Leukotriene A4 hydrolase inhibitor | 0.266 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.157 | 0.015 | 0.176 | Anabolic | 0.176 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.146 | 0.004 | 0.329 | Integrin beta3 antagonist | 0.329 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.158 | 0.018 | 0.158 | Transcription factor STAT6 inhibitor | 0.13 0.044 CHEMBL1157 | ||
| 0.141 | 0.003 | 0.262 | Glucose-6-phosphate isomerase inhibitor | 0.262 0.001 CHEMBL1157 | CHEMBL1157 | |
| 0.146 | 0.008 | 0.173 | Glycine receptor antagonist | 0.173 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.169 | 0.033 | 0.169 | Antibacterial (Helicobacter pylori) | 0.164 0.036 CHEMBL1157 | ||
| 0.137 | 0.002 | 0.137 | Membrane dipeptidase inhibitor | 0.131 0.002 CHEMBL1157 | ||
| 0.154 | 0.019 | 0.191 | Toll-Like receptor 4 antagonist | 0.191 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.157 | 0.024 | 0.215 | Caspase 3 inhibitor | 0.215 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.15 | 0.017 | 0.224 | Thioredoxin inhibitor | 0.224 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.138 | 0.005 | 0.138 | Kinesin-like protein 1 inhibitor | |||
| 0.138 | 0.005 | 0.138 | Kinesin antagonist | |||
| 0.185 | 0.053 | 0.38 | Protein-tyrosine phosphatase inhibitor | 0.38 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.136 | 0.005 | 0.316 | Prostaglandin F2 alpha antagonist | 0.316 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.158 | 0.027 | 0.19 | Sphingosine 1-phosphate receptor 4 antagonist | 0.19 0.011 CHEMBL1157 | CHEMBL1157 | |
| 0.197 | 0.068 | 0.197 | 5 Hydroxytryptamine 3E antagonist | 0.194 0.072 CHEMBL1157 | ||
| 0.143 | 0.016 | 0.224 | Keratolytic | 0.224 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.202 | 0.075 | 0.289 | Neurotrophic factor enhancer | 0.289 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.131 | 0.006 | 0.137 | NMDA receptor glycine site agonist | 0.137 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.153 | 0.029 | 0.202 | TRPA1 agonist | 0.202 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.129 | 0.005 | 0.129 | AMPA 2 receptor antagonist | 0.085 0.006 CHEMBL1157 | ||
| 0.162 | 0.039 | 0.308 | Cholesterol synthesis inhibitor | 0.308 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.128 | 0.005 | 0.128 | Phosphoglycerate kinase inhibitor | 0.089 0.008 CHEMBL1157 | ||
| 0.128 | 0.006 | 0.382 | Plasminogen activator inhibitor antagonist | 0.382 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.126 | 0.004 | 0.137 | Alpha-mannosidase inhibitor | 0.137 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.154 | 0.034 | 0.154 | GABA receptor agonist | 0.136 0.044 CHEMBL1157 | ||
| 0.12 | 0.001 | 0.12 | Carbonic anhydrase X inhibitor | 0.099 0.001 CHEMBL1157 | ||
| 0.12 | 0.001 | 0.12 | Carbonic anhydrase VIII inhibitor | 0.099 0.001 CHEMBL1157 | ||
| 0.123 | 0.004 | 0.134 | Glutamate (mGluR group III) antagonist | 0.134 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.12 | 0.002 | 0.157 | Glutamate (mGluR8) agonist | 0.157 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.135 | 0.019 | 0.165 | Glutamate (mGluR7) agonist | 0.165 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.131 | 0.014 | 0.158 | Vanilloid agonist | 0.158 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.129 | 0.012 | 0.129 | Glucagon-like peptide 1 agonist | 0.128 0.013 CHEMBL1157 | ||
| 0.119 | 0.005 | 0.172 | Thromboxane synthase inhibitor | 0.172 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.12 | 0.006 | 0.141 | Phospholipase D inhibitor | 0.141 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.128 | 0.014 | 0.162 | Bile acid receptor antagonist | 0.162 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.16 | 0.051 | 0.16 | Nav1.2 sodium channel blocker | 0.105 0.103 CHEMBL1157 | ||
| 0.122 | 0.014 | 0.57 | Prostaglandin antagonist | 0.57 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.123 | 0.014 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.118 0.018 CHEMBL1157 | ||
| 0.13 | 0.021 | 0.171 | Transcription factor NF kappa B stimulant | 0.171 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.124 | 0.016 | 0.124 | Ribonucleotide reductase inhibitor | 0.117 0.017 CHEMBL1157 | ||
| 0.113 | 0.006 | 0.113 | Complement C3a chemotactic receptor antagonist | 0.087 0.012 CHEMBL1157 | ||
| 0.144 | 0.037 | 0.16 | DNA repair enzyme inhibitor | 0.16 0.024 CHEMBL1157 | CHEMBL1157 | |
| 0.115 | 0.009 | 0.115 | Erythropoietin receptor agonist | 0.078 0.013 CHEMBL1157 | ||
| 0.127 | 0.023 | 0.206 | Interleukin 12 antagonist | 0.206 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.108 | 0.004 | 0.12 | Kainate receptor 2 antagonist | 0.12 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.111 | 0.008 | 0.111 | NMDA receptor subunit 3A antagonist | 0.111 0.007 CHEMBL1157 | ||
| 0.113 | 0.01 | 0.201 | Caspase 9 inhibitor | 0.201 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.122 | 0.019 | 0.122 | Myeloperoxidase inhibitor | 0.088 0.052 CHEMBL1157 | ||
| 0.112 | 0.01 | 0.134 | Vanilloid 4 agonist | 0.134 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.14 | 0.038 | 0.14 | Protein kinase C gamma inhibitor | 0.119 0.053 CHEMBL1157 | ||
| 0.106 | 0.004 | 0.238 | Vitronectin receptor antagonist | 0.238 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.141 | 0.04 | 0.141 | 5 Hydroxytryptamine 3A agonist | 0.107 0.068 CHEMBL1157 | ||
| 0.249 | 0.149 | 0.484 | Toll-Like receptor 7 agonist | 0.484 0.035 CHEMBL1157 | CHEMBL1157 | |
| 0.156 | 0.057 | 0.156 | Neuropeptide Y1 antagonist | 0.136 0.089 CHEMBL1157 | ||
| 0.102 | 0.004 | 0.106 | GABA uptake inhibitor | 0.106 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.125 | 0.027 | 0.182 | ErbB-3 antagonist | 0.182 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.112 | 0.014 | 0.141 | Estrogen-related receptor beta agonist | 0.141 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.133 | 0.036 | 0.295 | UDP-glucose 4-epimerase inhibitor | 0.295 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.131 | 0.034 | 0.146 | Sphingomyelinase inhibitor | 0.146 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.105 | 0.009 | 0.181 | CD45 antagonist | 0.181 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.103 | 0.006 | 0.103 | Somatostatin 2 antagonist | |||
| 0.1 | 0.004 | 0.159 | Glutamate (mGluR1a) agonist | 0.159 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.1 | 0.004 | 0.179 | Integrin alphaVbeta3 antagonist | 0.179 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.275 | 0.18 | 0.349 | Calcium channel L-type activator | 0.349 0.118 CHEMBL1157 | CHEMBL1157 | |
| 0.112 | 0.017 | 0.119 | Ribonucleoside-diphosphate reductase inhibitor | 0.119 0.016 CHEMBL1157 | CHEMBL1157 | |
| 0.099 | 0.005 | 0.139 | Lysophosphatidic acid 3 receptor antagonist | 0.139 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.098 | 0.004 | 0.098 | Kainate receptor 1 antagonist | 0.079 0.004 CHEMBL1157 | ||
| 0.097 | 0.003 | 0.126 | Kainate receptor agonist | 0.126 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.15 | 0.056 | 0.15 | Toll-Like receptor antagonist | 0.12 0.084 CHEMBL1157 | ||
| 0.103 | 0.01 | 0.154 | Thromboxane antagonist | 0.154 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.104 | 0.011 | 0.104 | AMPA receptor antagonist | 0.069 0.021 CHEMBL1157 | ||
| 0.095 | 0.003 | 0.095 | Carboxypeptidase B inhibitor | 0.053 0.005 CHEMBL1157 | ||
| 0.118 | 0.026 | 0.118 | Protein kinase B gamma inhibitor | |||
| 0.102 | 0.01 | 0.102 | Carbonic anhydrase XIV inhibitor | 0.091 0.013 CHEMBL1157 | ||
| 0.106 | 0.014 | 0.12 | Maillard reaction inhibitor | 0.12 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.095 | 0.004 | 0.095 | Geranyltranstransferase inhibitor | 0.082 0.005 CHEMBL1157 | ||
| 0.128 | 0.037 | 0.181 | Potassium channel (Ca-activated) activator | 0.181 0.019 CHEMBL1157 | CHEMBL1157 | |
| 0.15 | 0.059 | 0.168 | Neurotrophic factor | 0.168 0.045 CHEMBL1157 | CHEMBL1157 | |
| 0.102 | 0.012 | 0.102 | MAP kinase kinase 7 inhibitor | 0.097 0.015 CHEMBL1157 | ||
| 0.095 | 0.005 | 0.095 | Somatostatin 5 agonist | |||
| 0.095 | 0.005 | 0.118 | Retinoid X alpha receptor agonist | 0.118 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.139 | 0.051 | 0.214 | Monophenol monooxygenase inhibitor | 0.214 0.03 CHEMBL1157 | CHEMBL1157 | |
| 0.098 | 0.01 | 0.098 | Botulinum neurotoxin type A inhibitor | 0.073 0.022 CHEMBL1157 | ||
| 0.095 | 0.008 | 0.095 | Epithelial sodium channel blocker | 0.064 0.024 CHEMBL1157 | ||
| 0.093 | 0.006 | 0.11 | Sphingosine 1-phosphate receptor agonist | 0.11 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.094 | 0.007 | 0.094 | Somatostatin 1 antagonist | |||
| 0.095 | 0.009 | 0.142 | Thromboxane A2 antagonist | 0.142 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.092 | 0.005 | 0.129 | AICAR transformylase inhibitor | 0.129 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.224 | 0.138 | 0.308 | Caspase 3 stimulant | 0.308 0.075 CHEMBL1157 | CHEMBL1157 | |
| 0.099 | 0.014 | 0.099 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.089 0.023 CHEMBL1157 | ||
| 0.091 | 0.007 | 0.091 | Somatostatin 5 antagonist | |||
| 0.088 | 0.005 | 0.088 | Neurokinin 2 agonist | 0.046 0.023 CHEMBL1157 | ||
| 0.275 | 0.191 | 0.416 | Apoptosis agonist | 0.416 0.106 CHEMBL1157 | CHEMBL1157 | |
| 0.093 | 0.01 | 0.117 | MDM2 inhibitor | 0.117 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.092 | 0.01 | 0.092 | Calcitonin receptor agonist | 0.073 0.013 CHEMBL1157 | ||
| 0.086 | 0.005 | 0.093 | Dihydropteroate synthase inhibitor | 0.093 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.106 | 0.026 | 0.106 | Neuropeptide agonist | |||
| 0.085 | 0.005 | 0.092 | Sphingosine 1-phosphate receptor 1 agonist | 0.092 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.09 | 0.011 | 0.09 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.021 CHEMBL1157 | ||
| 0.085 | 0.006 | 0.107 | Thymidylate synthase inhibitor | 0.107 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.084 | 0.007 | 0.106 | Retinoid X receptor agonist | 0.106 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.132 | 0.055 | 0.152 | Beta amyloid protein antagonist | 0.152 0.039 CHEMBL1157 | CHEMBL1157 | |
| 0.093 | 0.015 | 0.128 | Glutamate (mGluR7) antagonist | 0.128 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.093 | 0.016 | 0.159 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.159 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.096 | 0.019 | 0.096 | Trypsin inhibitor | |||
| 0.085 | 0.009 | 0.085 | Growth hormone release inhibitor | |||
| 0.084 | 0.008 | 0.085 | Adenosine deaminase inhibitor | 0.085 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.147 | 0.071 | 0.254 | Lipid peroxidase inhibitor | 0.254 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.183 | 0.108 | 0.303 | Cyclic AMP phosphodiesterase inhibitor | 0.303 0.04 CHEMBL1157 | CHEMBL1157 | |
| 0.102 | 0.027 | 0.119 | D-Ala-D-Ala ligase inhibitor | 0.119 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.109 | 0.034 | 0.109 | Acetylcholine nicotinic antagonist | 0.082 0.052 CHEMBL1157 | ||
| 0.104 | 0.03 | 0.139 | Granulocyte macrophage colony stimulating factor agonist | 0.139 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.121 | 0.048 | 0.161 | AMP-activated protein kinase stimulant | 0.161 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.079 | 0.006 | 0.079 | Dopamine D5 agonist | 0.075 0.007 CHEMBL1157 | ||
| 0.085 | 0.012 | 0.126 | Sphingosine 1-phosphate receptor 1 antagonist | 0.126 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.099 | 0.027 | 0.231 | Leukotriene synthesis inhibitor | 0.231 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.106 | 0.034 | 0.106 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.091 | 0.02 | 0.16 | Purinergic P2X1 antagonist | 0.16 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.098 | 0.027 | 0.098 | Thrombin inhibitor | |||
| 0.125 | 0.055 | 0.191 | Microtubule formation inhibitor | 0.191 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.083 | 0.013 | 0.089 | Angiotensin-converting enzyme inhibitor | 0.089 0.011 CHEMBL1157 | CHEMBL1157 | |
| 0.081 | 0.012 | 0.213 | Macrophage elastase inhibitor | 0.213 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.089 | 0.021 | 0.089 | Plasminogen activator inhibitor | |||
| 0.103 | 0.035 | 0.103 | CYP2A6 inhibitor | 0.081 0.048 CHEMBL1157 | ||
| 0.083 | 0.015 | 0.098 | Sphingosine 1-phosphate receptor 3 antagonist | 0.098 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.072 | 0.004 | 0.098 | Glutamate (mGluR8) antagonist | 0.098 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.088 | 0.021 | 0.088 | Aminopeptidase microsomal inhibitor | 0.079 0.025 CHEMBL1157 | ||
| 0.097 | 0.03 | 0.337 | Peroxisome proliferator-activated receptor gamma agonist | 0.337 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.083 | 0.016 | 0.083 | Bombesin 2 receptor antagonist | 0.077 0.018 CHEMBL1157 | ||
| 0.19 | 0.123 | 0.229 | Calpain inhibitor | 0.229 0.086 CHEMBL1157 | CHEMBL1157 | |
| 0.077 | 0.011 | 0.077 | Carbonic anhydrase II stimulant | 0.06 0.024 CHEMBL1157 | ||
| 0.074 | 0.008 | 0.184 | Cholecystokinin B agonist | 0.184 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.124 | 0.06 | 0.303 | Protein-tyrosine phosphatase 1B inhibitor | 0.303 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.073 | 0.009 | 0.073 | Factor XIIIa inhibitor | 0.042 0.021 CHEMBL1157 | ||
| 0.076 | 0.012 | 0.076 | Carbonic anhydrase IV inhibitor | 0.067 0.016 CHEMBL1157 | ||
| 0.069 | 0.005 | 0.08 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.08 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.004 | 0.402 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.402 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.066 | 0.003 | 0.092 | Glutamate (mGluR3) agonist | 0.092 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.1 | 0.038 | 0.121 | Metalloproteinase-2 inhibitor | 0.121 0.029 CHEMBL1157 | CHEMBL1157 | |
| 0.069 | 0.007 | 0.069 | Dihydrofolate reductase inhibitor | 0.067 0.007 CHEMBL1157 | ||
| 0.201 | 0.139 | 0.311 | Lipoxygenase inhibitor | 0.311 0.066 CHEMBL1157 | CHEMBL1157 | |
| 0.082 | 0.02 | 0.095 | Nitric oxide donor | 0.095 0.011 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.005 | 0.098 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.098 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.074 | 0.013 | 0.099 | Ryanodine receptor antagonist | 0.099 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.128 | 0.067 | 0.128 | Cholinergic antagonist | 0.102 0.093 CHEMBL1157 | ||
| 0.064 | 0.004 | 0.064 | Urotensin II agonist | 0.035 0.012 CHEMBL1157 | ||
| 0.076 | 0.017 | 0.129 | Leukotriene B4 antagonist | 0.129 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.098 | 0.039 | 0.098 | Factor XII inhibitor | |||
| 0.123 | 0.064 | 0.123 | Anesthetic local | 0.122 0.065 CHEMBL1157 | ||
| 0.066 | 0.007 | 0.073 | Guanylate cyclase inhibitor | 0.073 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.071 | 0.013 | 0.108 | Leukotriene C antagonist | 0.108 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.009 | 0.067 | Dopamine beta hydroxylase inhibitor | 0.065 0.011 CHEMBL1157 | ||
| 0.134 | 0.076 | 0.134 | Nav1.6 sodium channel blocker | 0.134 0.075 CHEMBL1157 | ||
| 0.089 | 0.031 | 0.134 | Sphingosine 1-phosphate receptor antagonist | 0.134 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.065 | 0.007 | 0.131 | Glucagon-like peptide 1 receptor antagonist | 0.131 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.103 | 0.046 | 0.103 | Protein kinase C zeta inhibitor | 0.089 0.068 CHEMBL1157 | ||
| 0.085 | 0.029 | 0.099 | Neutrophil collagenase inhibitor | 0.099 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.121 | 0.065 | 0.144 | Proteasome inhibitor | 0.144 0.05 CHEMBL1157 | CHEMBL1157 | |
| 0.063 | 0.007 | 0.063 | Somatostatin 4 antagonist | |||
| 0.121 | 0.065 | 0.121 | Acetylcholine muscarinic antagonist | 0.105 0.085 CHEMBL1157 | ||
| 0.066 | 0.01 | 0.092 | Integrin alpha5beta1 antagonist | 0.092 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.012 | 0.067 | Oxytocin agonist | 0.06 0.017 CHEMBL1157 | ||
| 0.067 | 0.012 | 0.067 | Histamine H2 receptor agonist | 0.048 0.024 CHEMBL1157 | ||
| 0.078 | 0.023 | 0.078 | Plasmin inhibitor | |||
| 0.07 | 0.015 | 0.136 | Glutamate (mGluR group III) agonist | 0.136 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.064 | 0.01 | 0.064 | Neuraminidase (Influenza A) inhibitor | 0.056 0.017 CHEMBL1157 | ||
| 0.079 | 0.025 | 0.13 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.13 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.123 | 0.068 | 0.123 | Acetylcholine antagonist | 0.098 0.095 CHEMBL1157 | ||
| 0.113 | 0.059 | 0.139 | Falcipain 3 inhibitor | 0.139 0.042 CHEMBL1157 | CHEMBL1157 | |
| 0.059 | 0.005 | 0.123 | Prostaglandin D2 agonist | 0.123 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.064 | 0.01 | 0.064 | Carbonic anhydrase I stimulant | 0.036 0.028 CHEMBL1157 | ||
| 0.06 | 0.007 | 0.062 | Peptide deformylase inhibitor | 0.062 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.095 | 0.042 | 0.095 | Topoisomerase II alpha inhibitor | 0.07 0.062 CHEMBL1157 | ||
| 0.061 | 0.008 | 0.083 | Glucagon receptor antagonist | 0.083 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.083 | 0.03 | 0.167 | Leukotriene antagonist | 0.167 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.057 | 0.004 | 0.118 | Glutamate (mGluR1) agonist | 0.118 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.063 | 0.011 | 0.063 | Cytokine production stimulant | 0.057 0.016 CHEMBL1157 | ||
| 0.056 | 0.004 | 0.084 | Prostaglandin F2 alpha agonist | 0.084 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.059 | 0.007 | 0.059 | Dipeptidyl peptidase II inhibitor | 0.033 0.022 CHEMBL1157 | ||
| 0.062 | 0.01 | 0.062 | Parathyroid hormone antagonist | 0.043 0.038 CHEMBL1157 | ||
| 0.054 | 0.004 | 0.075 | Lysophosphatidic acid receptor 1 agonist | 0.075 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.059 | 0.01 | 0.059 | Sirtuin 2 inhibitor | 0.032 0.023 CHEMBL1157 | ||
| 0.14 | 0.091 | 0.201 | Hexokinase inhibitor | 0.201 0.035 CHEMBL1157 | CHEMBL1157 | |
| 0.077 | 0.028 | 0.077 | Neuraminidase (influenza) inhibitor | 0.075 0.029 CHEMBL1157 | ||
| 0.059 | 0.01 | 0.266 | Prostacyclin antagonist | 0.266 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.065 | 0.017 | 0.113 | Purinergic P2Y antagonist | 0.113 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.057 | 0.009 | 0.057 | Tryptase inhibitor | |||
| 0.051 | 0.004 | 0.051 | Purinergic P2Y15 antagonist | 0.043 0.005 CHEMBL1157 | ||
| 0.105 | 0.059 | 0.151 | Gastric antisecretory | 0.151 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.021 | 0.067 | Aminopeptidase N inhibitor | 0.059 0.025 CHEMBL1157 | ||
| 0.068 | 0.022 | 0.068 | Beta 2 adrenoreceptor agonist | 0.066 0.028 CHEMBL1157 | ||
| 0.075 | 0.029 | 0.075 | Neuraminidase inhibitor | 0.072 0.032 CHEMBL1157 | ||
| 0.106 | 0.06 | 0.113 | Urease inhibitor | 0.113 0.053 CHEMBL1157 | CHEMBL1157 | |
| 0.048 | 0.002 | 0.104 | Glutamate (mGluR6) agonist | 0.104 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.063 | 0.017 | 0.154 | Cholecystokinin antagonist | 0.154 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.149 | 0.103 | 0.218 | ATPase inhibitor | 0.218 0.025 CHEMBL1157 | CHEMBL1157 | |
| 0.071 | 0.026 | 0.071 | Histone deacetylase SIRT3 inhibitor | |||
| 0.07 | 0.025 | 0.082 | Sphingosine kinase inhibitor | 0.082 0.015 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.003 | 0.047 | Carboxypeptidase B2 inhibitor | 0.016 0.005 CHEMBL1157 | ||
| 0.048 | 0.004 | 0.067 | Prostaglandin H2 antagonist | 0.067 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.095 | 0.051 | 0.095 | Opioid antagonist | |||
| 0.049 | 0.005 | 0.049 | Calcium-sensing receptor agonist | 0.036 0.009 CHEMBL1157 | ||
| 0.14 | 0.096 | 0.18 | CF transmembrane conductance regulator agonist | 0.18 0.036 CHEMBL1157 | CHEMBL1157 | |
| 0.052 | 0.009 | 0.063 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.063 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.075 | 0.032 | 0.098 | Exportin-1 inhibitor | 0.098 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.065 | 0.021 | 0.097 | Pregnane X receptor antagonist | 0.097 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.075 | 0.032 | 0.077 | Beta adrenoreceptor antagonist | 0.077 0.029 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.025 | 0.08 | Lipocortins synthesis agonist | 0.08 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.054 | 0.012 | 0.054 | Somatostatin agonist | |||
| 0.104 | 0.062 | 0.112 | Protease inhibitor | 0.112 0.054 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.007 | 0.056 | Tryptophan 5 hydroxylase inhibitor | 0.056 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.122 | 0.082 | 0.191 | Interleukin 4 antagonist | 0.191 0.025 CHEMBL1157 | CHEMBL1157 | |
| 0.086 | 0.045 | 0.14 | Macrophage migration inhibitory factor inhibitor | 0.14 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.05 | 0.009 | 0.13 | VCAM-1 antagonist | 0.13 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.049 | 0.009 | 0.132 | VCAM antagonist | 0.132 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.042 | 0.002 | 0.042 | Carbonic anhydrase XI inhibitor | 0.04 0.002 CHEMBL1157 | ||
| 0.066 | 0.027 | 0.072 | Matrix metalloproteinase (membrane-type) inhibitor | 0.072 0.023 CHEMBL1157 | CHEMBL1157 | |
| 0.062 | 0.023 | 0.062 | Beta 2 adrenoreceptor antagonist | 0.061 0.023 CHEMBL1157 | ||
| 0.081 | 0.042 | 0.206 | CDC25A inhibitor | 0.206 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.076 | 0.038 | 0.076 | Opioid delta receptor antagonist | |||
| 0.047 | 0.009 | 0.148 | Lysophosphatidic acid 2 receptor antagonist | 0.148 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.092 | 0.054 | 0.111 | Calcium antagonist | 0.111 0.04 CHEMBL1157 | CHEMBL1157 | |
| 0.042 | 0.005 | 0.203 | Prostacyclin agonist | 0.203 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.045 | 0.007 | 0.091 | Prostaglandin EP2 agonist | 0.091 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.06 | 0.023 | 0.081 | Heparanase inhibitor | 0.081 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.01 | 0.081 | Integrin alpha1beta1 antagonist | 0.081 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.01 | 0.047 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.141 | 0.104 | 0.325 | Dual specificity phosphatase inhibitor | 0.325 0.025 CHEMBL1157 | CHEMBL1157 | |
| 0.039 | 0.003 | 0.067 | Thromboxane A2 agonist | 0.067 0.001 CHEMBL1157 | CHEMBL1157 | |
| 0.075 | 0.038 | 0.075 | Protein kinase C beta inhibitor | 0.074 0.039 CHEMBL1157 | ||
| 0.161 | 0.125 | 0.188 | Histone acetyltransferase inhibitor | 0.188 0.087 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.011 | 0.168 | Prostaglandin agonist | 0.168 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.086 | 0.05 | 0.087 | Adrenaline agonist | 0.087 0.049 CHEMBL1157 | CHEMBL1157 | |
| 0.045 | 0.009 | 0.293 | Leukotriene B4 receptor 1 antagonist | 0.293 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.04 | 0.004 | 0.047 | Aminopeptidase A inhibitor | 0.047 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.045 | 0.01 | 0.148 | ATP citrate lysase inhibitor | 0.148 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.051 | 0.015 | 0.092 | Sphingosine 1-phosphate receptor 3 agonist | 0.092 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.048 | 0.012 | 0.081 | Leukotriene C4 antagonist | 0.081 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.039 | 0.004 | 0.047 | Vanilloid 2 agonist | 0.047 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.084 | 0.049 | 0.101 | Glutamate receptor agonist | 0.101 0.037 CHEMBL1157 | CHEMBL1157 | |
| 0.058 | 0.023 | 0.06 | Squalene epoxidase inhibitor | 0.06 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.044 | 0.01 | 0.065 | Uridine phosphorylase inhibitor | 0.065 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.043 | 0.008 | 0.174 | Purinergic P2Y12 antagonist | 0.174 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.053 | 0.018 | 0.121 | Cholecystokinin A antagonist | 0.121 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.014 | 0.13 | VLA-4 antagonist | 0.13 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.07 | 0.037 | 0.088 | Protease 3C (Human rhinovirus) inhibitor | 0.088 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.074 | 0.041 | 0.085 | Matrix metalloproteinase inhibitor | 0.085 0.034 CHEMBL1157 | CHEMBL1157 | |
| 0.051 | 0.017 | 0.051 | Histamine H1 receptor agonist | 0.041 0.037 CHEMBL1157 | ||
| 0.048 | 0.014 | 0.07 | Retinoid X receptor antagonist | 0.07 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.046 | 0.013 | 0.124 | Caspase 2 inhibitor | 0.124 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.04 | 0.006 | 0.106 | Integrin beta5 antagonist | 0.106 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.078 | 0.044 | 0.1 | Epoxide hydrolase inhibitor | 0.1 0.025 CHEMBL1157 | CHEMBL1157 | |
| 0.041 | 0.008 | 0.047 | LFA antagonist | 0.047 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.014 | 0.066 | Integrin alpha2 antagonist | 0.066 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.054 | 0.022 | 0.075 | Adenylate cyclase 1 inhibitor | 0.075 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.051 | 0.018 | 0.063 | Thymidine kinase inhibitor | 0.063 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.048 | 0.016 | 0.048 | Diamine oxidase inhibitor | |||
| 0.039 | 0.007 | 0.06 | Thyroid hormone agonist | 0.06 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.041 | 0.009 | 0.117 | Kynurenine 3 monooxygenase inhibitor | 0.117 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.057 | 0.026 | 0.067 | Metalloproteinase-3 inhibitor | 0.067 0.02 CHEMBL1157 | CHEMBL1157 | |
| 0.046 | 0.016 | 0.046 | Antibiotic Aminoglycoside-like | |||
| 0.04 | 0.01 | 0.04 | Growth hormone releasing factor antagonist | |||
| 0.065 | 0.035 | 0.065 | Glutamate (mGluR1) antagonist | 0.052 0.046 CHEMBL1157 | ||
| 0.034 | 0.004 | 0.034 | Toll-Like receptor 8 agonist | 0.02 0.013 CHEMBL1157 | ||
| 0.04 | 0.011 | 0.054 | Calcium-independent phospholipase A2 inhibitor | 0.054 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.032 | 0.003 | 0.056 | Lysophosphatidic acid receptor 3 agonist | 0.056 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.062 | 0.033 | 0.069 | Beta 1 adrenoreceptor antagonist | 0.069 0.027 CHEMBL1157 | CHEMBL1157 | |
| 0.059 | 0.031 | 0.085 | Adenine nucleotide translocase inhibitor | 0.085 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.039 | 0.076 | Beta 3 adrenoreceptor antagonist | 0.076 0.027 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.005 | 0.111 | Integrin alphaVbeta1 antagonist | 0.111 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.059 | 0.033 | 0.07 | Sphingosine kinase 2 inhibitor | 0.07 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.042 | 0.016 | 0.042 | Trypsin I inhibitor | |||
| 0.18 | 0.154 | 0.18 | 5 Hydroxytryptamine 1E antagonist | 0.179 0.156 CHEMBL1157 | ||
| 0.047 | 0.021 | 0.047 | Plasmepsin II inhibitor | 0.038 0.035 CHEMBL1157 | ||
| 0.099 | 0.074 | 0.099 | DNA intercalator | |||
| 0.071 | 0.046 | 0.071 | Opioid mu receptor antagonist | |||
| 0.038 | 0.013 | 0.047 | Methionyl aminopeptidase 1 inhibitor | 0.047 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.036 | 0.011 | 0.058 | NMDA 2D receptor antagonist | 0.058 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.055 | 0.03 | 0.097 | Diacylglycerol O-acyltransferase inhibitor | 0.097 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.074 | 0.049 | 0.091 | Metalloproteinase-9 inhibitor | 0.091 0.037 CHEMBL1157 | CHEMBL1157 | |
| 0.04 | 0.016 | 0.082 | Glutamate (mGluR4) agonist | 0.082 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.053 | 0.028 | 0.073 | HCV NS3/NS4A protease inhibitor | 0.073 0.013 CHEMBL1157 | CHEMBL1157 | |
| 0.057 | 0.033 | 0.1 | DNA helicase inhibitor | 0.1 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.049 | 0.025 | 0.049 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 CHEMBL1157 | ||
| 0.097 | 0.073 | 0.097 | Topoisomerase I inhibitor | 0.091 0.078 CHEMBL1157 | ||
| 0.029 | 0.005 | 0.046 | Retinoid X beta receptor antagonist | 0.046 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.035 | 0.011 | 0.057 | Kainate receptor 4 antagonist | 0.057 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.003 | 0.031 | Methylmalonyl-CoA mutase inhibitor | 0.031 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.039 | 0.016 | 0.058 | Retinoid X alpha receptor antagonist | 0.058 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.006 | 0.034 | Isoleucine-tRNA ligase inhibitor | 0.034 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.036 | 0.013 | 0.036 | Thrombin receptor antagonist | |||
| 0.028 | 0.005 | 0.03 | Neuraminidase (Influenza B) inhibitor | 0.03 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.053 | 0.031 | 0.053 | Urokinase inhibitor | |||
| 0.031 | 0.009 | 0.031 | Somatostatin 3 antagonist | |||
| 0.036 | 0.014 | 0.217 | Integrin alpha4 antagonist | 0.217 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.036 | 0.014 | 0.054 | Epoxide hydrolase 1 inhibitor | 0.054 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.07 | 0.049 | 0.07 | CXC chemokine receptor antagonist | |||
| 0.061 | 0.039 | 0.076 | Potassium channel intermediate-conductance Ca-activated blocker | 0.076 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.102 | 0.082 | 0.145 | Acetylcholine release stimulant | 0.145 0.02 CHEMBL1157 | CHEMBL1157 | |
| 0.024 | 0.004 | 0.024 | Integrin alphaVbeta5 antagonist | 0.021 0.004 CHEMBL1157 | ||
| 0.031 | 0.011 | 0.04 | Hedgehog signaling activator | 0.04 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.023 | 0.003 | 0.071 | Thromboxane agonist | 0.071 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.006 | 0.044 | Ileal bile acid transport inhibitor | 0.044 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.024 | 0.004 | 0.024 | Integrin alphaVbeta6 antagonist | 0.023 0.005 CHEMBL1157 | ||
| 0.027 | 0.008 | 0.057 | Lysophosphatidic acid 1 receptor antagonist | 0.057 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.036 | 0.017 | 0.093 | Cholecystokinin B antagonist | 0.093 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.035 | 0.017 | 0.035 | Factor VII inhibitor | |||
| 0.072 | 0.053 | 0.072 | Histone deacetylase SIRT2 inhibitor | |||
| 0.029 | 0.011 | 0.122 | Prostaglandin E2 agonist | 0.122 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.033 | 0.015 | 0.033 | Bradykinin B2 receptor agonist | |||
| 0.025 | 0.008 | 0.126 | Prostaglandin EP4 agonist | 0.126 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.014 | 0.031 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.021 | 0.004 | 0.034 | Integrin beta6 antagonist | 0.034 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.055 | 0.038 | 0.073 | Glucosylceramidase inhibitor | 0.073 0.02 CHEMBL1157 | CHEMBL1157 | |
| 0.023 | 0.007 | 0.026 | Antibiotic Anthracycline-like | 0.026 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.004 | 0.063 | Calcium-dependent phospholipase A2 inhibitor | 0.063 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.015 | 0.031 | Vasopressin 1A agonist | |||
| 0.027 | 0.011 | 0.055 | Kainate receptor 5 antagonist | 0.055 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.036 | 0.02 | 0.071 | HMG CoA reductase inhibitor | 0.071 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.066 | 0.05 | 0.117 | Potassium channel large-conductance Ca-activated activator | 0.117 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.08 | 0.065 | 0.08 | Histamine H2 receptor antagonist | |||
| 0.12 | 0.105 | 0.242 | Farnesoid X receptor antagonist | 0.242 0.013 CHEMBL1157 | CHEMBL1157 | |
| 0.052 | 0.037 | 0.052 | Dipeptidyl peptidase inhibitor | |||
| 0.065 | 0.05 | 0.065 | Neuronal nicotinic receptor antagonist | |||
| 0.023 | 0.009 | 0.033 | Caspase 8 inhibitor | 0.033 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.011 | 0.026 | Neurokinin 1 agonist | |||
| 0.052 | 0.037 | 0.052 | Histamine agonist | |||
| 0.03 | 0.015 | 0.03 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.027 0.02 CHEMBL1157 | ||
| 0.02 | 0.006 | 0.02 | CXC chemokine 4 receptor agonist | |||
| 0.045 | 0.031 | 0.046 | Beta adrenoreceptor agonist | 0.046 0.029 CHEMBL1157 | CHEMBL1157 | |
| 0.027 | 0.013 | 0.329 | Prostaglandin D2 antagonist | 0.329 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.015 | 0.042 | Retinoid X gamma receptor antagonist | 0.042 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.037 | 0.023 | 0.05 | Ceramide glucosyltransferase inhibitor | 0.05 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.105 | 0.091 | 0.105 | Glutamate receptor antagonist | |||
| 0.029 | 0.016 | 0.102 | Prostaglandin EP4 antagonist | 0.102 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.022 | 0.009 | 0.27 | Free fatty acid receptor 1 agonist | 0.27 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.034 | 0.119 | Peroxisome proliferator-activated receptor alpha agonist | 0.119 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.088 | 0.075 | 0.162 | Xanthine oxidase inhibitor | 0.162 0.03 CHEMBL1157 | CHEMBL1157 | |
| 0.045 | 0.033 | 0.077 | Phosphorylase inhibitor | 0.077 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.015 | 0.002 | 0.017 | Integrin alpha5beta6 antagonist | 0.017 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.099 | 0.087 | 0.099 | Topoisomerase II inhibitor | |||
| 0.069 | 0.057 | 0.109 | Peroxisome proliferator-activated receptor gamma antagonist | 0.109 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.042 | 0.03 | 0.057 | Angiotensin AT1 receptor antagonist | 0.057 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.02 | 0.008 | 0.027 | Telomerase stimulant | 0.027 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.057 | 0.045 | 0.057 | Cyclin A1 inhibitor | |||
| 0.02 | 0.009 | 0.036 | Kainate receptor 3 antagonist | 0.036 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.045 | 0.034 | 0.07 | Endothelin-converting enzyme inhibitor | 0.07 0.02 CHEMBL1157 | CHEMBL1157 | |
| 0.025 | 0.014 | 0.086 | Retinoid X gamma receptor agonist | 0.086 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.046 | 0.035 | 0.046 | Melanocortin antagonist | |||
| 0.022 | 0.012 | 0.068 | Cholecystokinin agonist | 0.068 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.037 | 0.026 | 0.132 | 5-Alpha-reductase inhibitor | 0.132 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.074 | 0.064 | 0.101 | Chymotrypsin inhibitor | 0.101 0.035 CHEMBL1157 | CHEMBL1157 | |
| 0.048 | 0.038 | 0.066 | Prolyl endopeptidase inhibitor | 0.066 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.018 | 0.009 | 0.027 | Vitamin D receptor agonist | 0.027 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.042 | 0.033 | 0.08 | Guanylate cyclase stimulant | 0.08 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.019 | 0.01 | 0.099 | G-protein-coupled receptor 120 agonist | 0.099 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.018 | 0.037 | Integrin alpha2beta1 antagonist | 0.037 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.033 | 0.025 | 0.047 | Angiotensin II receptor antagonist | 0.047 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.023 | 0.015 | 0.026 | ICAM 1 antagonist | 0.026 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.023 | 0.015 | 0.084 | Purinergic P2T antagonist | 0.084 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.018 | 0.01 | 0.05 | Cholecystokinin A agonist | 0.05 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.043 | 0.035 | 0.07 | Fructose-1,6-bisphosphatase inhibitor | 0.07 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.011 | 0.003 | 0.029 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.029 0.002 CHEMBL1157 | CHEMBL1157 | |
| 0.025 | 0.018 | 0.028 | Complement factor 1s inhibitor | 0.028 0.011 CHEMBL1157 | CHEMBL1157 | |
| 0.116 | 0.109 | 0.223 | Mannose-6-phosphate isomerase inhibitor | 0.223 0.02 CHEMBL1157 | CHEMBL1157 | |
| 0.039 | 0.033 | 0.049 | Sphingosine kinase 1 inhibitor | 0.049 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.069 | 0.063 | 0.133 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.133 0.024 CHEMBL1157 | CHEMBL1157 | |
| 0.032 | 0.026 | 0.078 | Free fatty acid receptor 1 antagonist | 0.078 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.032 | 0.027 | 0.053 | Carnitine palmitoyltransferase inhibitor | 0.053 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.033 | 0.028 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.036 0.023 CHEMBL1157 | CHEMBL1157 | |
| 0.062 | 0.057 | 0.062 | Protein kinase C alpha inhibitor | |||
| 0.042 | 0.037 | 0.042 | Opioid mu receptor agonist | |||
| 0.015 | 0.01 | 0.015 | Somatostatin 2 agonist | |||
| 0.016 | 0.011 | 0.021 | Purinergic P2Y1 agonist | 0.021 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.016 | 0.071 | Leukotriene B4 receptor 2 antagonist | 0.071 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.035 | 0.03 | 0.035 | Melanocortin 1 antagonist | |||
| 0.015 | 0.011 | 0.109 | Thyroid hormone alpha antagonist | 0.109 0.003 CHEMBL1157 | CHEMBL1157 | |
| 0.038 | 0.034 | 0.038 | Melanocortin 4 antagonist | |||
| 0.019 | 0.014 | 0.106 | 5-Alpha-reductase 2 inhibitor | 0.106 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.039 | 0.035 | 0.039 | GHS receptor agonist | |||
| 0.017 | 0.013 | 0.02 | Tryptophan hydroxylase 1 inhibitor | 0.02 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.04 | 0.036 | 0.062 | Nerve growth factor antagonist | 0.062 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.011 | 0.008 | 0.011 | Neurokinin 3 agonist | 0.01 0.009 CHEMBL1157 | ||
| 0.041 | 0.038 | 0.041 | Dipeptidyl peptidase IV inhibitor | |||
| 0.008 | 0.006 | 0.01 | Free fatty acid receptor 2 antagonist | 0.01 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.028 | 0.086 | Peroxisome proliferator-activated receptor delta agonist | 0.086 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.011 | 0.013 | Glucagon agonist | |||
| 0.031 | 0.029 | 0.208 | Peroxisome proliferator-activated receptor delta antagonist | 0.208 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.012 | 0.011 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.012 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.015 | 0.014 | 0.032 | Thyroid hormone alpha agonist | 0.032 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.03 | 0.05 | Carnitine palmitoyltransferase 1 inhibitor | 0.05 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.019 | 0.018 | 0.074 | Retinoid X beta receptor agonist | 0.074 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.032 | 0.032 | 0.033 | AMPA receptor agonist | 0.033 0.029 CHEMBL1157 | CHEMBL1157 | |
| 0.018 | 0.017 | 0.063 | Neutral endopeptidase inhibitor | 0.063 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.062 | 0.062 | 0.088 | Amidase inhibitor | 0.088 0.031 CHEMBL1157 | CHEMBL1157 | |
| 0.022 | 0.023 | 0.206 | Leukotriene D4 antagonist | 0.206 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.025 | 0.026 | 0.192 | Prostaglandin EP3 antagonist | 0.192 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.01 | 0.011 | 0.013 | Purine nucleoside phosphorylase inhibitor | 0.013 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.04 | 0.042 | 0.055 | Heme oxygenase inhibitor | 0.055 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.028 | 0.035 | Estrogen-related receptor gamma antagonist | 0.035 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.028 | 0.08 | Squalene synthetase inhibitor | 0.08 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.016 | 0.019 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.034 | 0.037 | HCV polyprotein inhibitor | 0.037 0.016 CHEMBL1157 | CHEMBL1157 | |
| 0.007 | 0.01 | 0.015 | Thyroid hormone beta agonist | 0.015 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.023 | 0.027 | 0.026 | Acid ceramidase inhibitor | 0.026 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.051 | 0.055 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.061 0.023 CHEMBL1157 | CHEMBL1157 | |
| 0.012 | 0.017 | 0.087 | 5-Alpha-reductase 1 inhibitor | 0.087 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.027 | 0.031 | 0.05 | Caspase 6 inhibitor | 0.05 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.036 | 0.063 | p53 inhibitor | 0.063 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.019 | 0.027 | 0.03 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.03 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.024 | 0.031 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.014 | 0.021 | 0.065 | Integrin beta7 antagonist | 0.065 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.043 | 0.05 | 0.05 | Collagenase inhibitor | 0.05 0.033 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.039 | 0.089 | Urate transporter 1 inhibitor | 0.089 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.008 | 0.017 | 0.015 | Integrin beta2 antagonist | 0.015 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.009 | 0.018 | 0.024 | Integrin alpha4beta1 antagonist | 0.024 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.009 | 0.018 | 0.019 | Angiotensin AT1B receptor antagonist | 0.019 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.022 | 0.032 | 0.028 | Thymidine phosphorylase inhibitor | 0.028 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.084 | 0.094 | 0.106 | Protein kinase (CK2) alpha inhibitor | 0.106 0.071 CHEMBL1157 | CHEMBL1157 | |
| 0.072 | 0.082 | 0.123 | Caspase 7 inhibitor | 0.123 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.004 | 0.014 | 0.008 | DNA polymerase III subunit alpha inhibitor | 0.008 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.032 | 0.044 | Nicotinic acid receptor 2 antagonist | 0.044 0.004 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.024 | 0.026 | Nicotinic acid receptor 1 antagonist | 0.026 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.042 | 0.045 | Glutamate (mGluR group II) antagonist | 0.045 0.019 CHEMBL1157 | CHEMBL1157 | |
| 0.01 | 0.021 | 0.024 | Egl nine homolog 1 inhibitor | 0.024 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.025 | 0.062 | Integrin alpha4beta7 antagonist | 0.062 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.035 | 0.048 | 0.042 | Carbonic anhydrase VII inhibitor | 0.042 0.038 CHEMBL1157 | CHEMBL1157 | |
| 0.017 | 0.03 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.025 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.012 | 0.026 | 0.017 | Angiotensin-converting enzyme 2 inhibitor | 0.017 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.074 | 0.088 | 0.095 | Interleukin 5 antagonist | 0.095 0.048 CHEMBL1157 | CHEMBL1157 | |
| 0.1 | 0.114 | 0.14 | NADPH oxidase inhibitor | 0.14 0.062 CHEMBL1157 | CHEMBL1157 | |
| 0.121 | 0.135 | 0.2 | Nitric oxide antagonist | 0.2 0.067 CHEMBL1157 | CHEMBL1157 | |
| 0.048 | 0.062 | 0.08 | Collagenase 3 inhibitor | 0.08 0.024 CHEMBL1157 | CHEMBL1157 | |
| 0.019 | 0.034 | 0.048 | Liver X receptor beta antagonist | 0.048 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.083 | 0.098 | 0.113 | Phosphodiesterase 6D inhibitor | 0.113 0.032 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.045 | 0.042 | DNA gyrase subunit B inhibitor | 0.042 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.103 | 0.119 | 0.115 | Interleukin 1 antagonist | 0.115 0.097 CHEMBL1157 | CHEMBL1157 | |
| 0.056 | 0.072 | 0.062 | Transcription factor RelA inhibitor | 0.062 0.05 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.042 | 0.076 | Nicotinic acid receptor agonist | 0.076 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.045 | 0.039 | Histone deacetylase 7 inhibitor | 0.039 0.024 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.067 | 0.058 | Acetyl-CoA transferase 2 inhibitor | 0.058 0.034 CHEMBL1157 | CHEMBL1157 | |
| 0.032 | 0.051 | 0.062 | Leukocyte elastase inhibitor | 0.062 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.006 | 0.027 | 0.012 | Calcineurin inhibitor | 0.012 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.073 | 0.095 | 0.094 | CC chemokine 5 receptor agonist | 0.094 0.03 CHEMBL1157 | CHEMBL1157 | |
| 0.007 | 0.029 | 0.015 | Egl nine homolog 3 inhibitor | 0.015 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.059 | 0.081 | 0.078 | Nicotinic alpha4beta2 receptor antagonist | 0.078 0.052 CHEMBL1157 | CHEMBL1157 | |
| 0.028 | 0.05 | 0.033 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.033 0.032 CHEMBL1157 | CHEMBL1157 | |
| 0.036 | 0.059 | 0.189 | Aldose reductase inhibitor | 0.189 0.008 CHEMBL1157 | CHEMBL1157 | |
| 0.008 | 0.031 | 0.058 | Peroxisome proliferator-activated receptor alpha antagonist | 0.058 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.019 | 0.043 | 0.058 | Protocollagen prolyl hydroxylase inhibitor | 0.058 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.046 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.066 | 0.091 | 0.113 | Antineoplastic alkaloid | 0.113 0.041 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.038 | 0.02 | Corticosteroid-like | 0.02 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.014 | 0.039 | 0.02 | Geranylgeranyltransferase inhibitor | 0.02 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.047 | 0.072 | 0.056 | Cathepsin E inhibitor | 0.056 0.046 CHEMBL1157 | CHEMBL1157 | |
| 0.056 | 0.083 | 0.116 | HIV-1 integrase inhibitor | 0.116 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.022 | 0.049 | 0.027 | DNA polymerase III inhibitor | 0.027 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.116 | 0.143 | 0.168 | Pregnane X receptor agonist | 0.168 0.028 CHEMBL1157 | CHEMBL1157 | |
| 0.015 | 0.042 | 0.096 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.096 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.058 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.03 CHEMBL1157 | CHEMBL1157 | |
| 0.193 | 0.221 | 0.294 | 15-Lipoxygenase inhibitor | 0.294 0.136 CHEMBL1157 | CHEMBL1157 | |
| 0.074 | 0.103 | 0.167 | ABCA1 expression enhancer | 0.167 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.057 | 0.033 | Adenosine uptake inhibitor | 0.033 0.029 CHEMBL1157 | CHEMBL1157 | |
| 0.038 | 0.067 | 0.058 | Topoisomerase II beta inhibitor | 0.058 0.024 CHEMBL1157 | CHEMBL1157 | |
| 0.048 | 0.078 | 0.131 | CDC25B inhibitor | 0.131 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.018 | 0.049 | 0.027 | Histone deacetylase class IV inhibitor | 0.027 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.018 | 0.049 | 0.027 | Histone deacetylase 11 inhibitor | 0.027 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.044 | 0.029 | NMDA receptor glycine site antagonist | 0.029 0.013 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.046 | 0.028 | Retinoic acid beta receptor agonist | 0.028 0.006 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.056 | 0.062 | Farnesoid X receptor agonist | 0.062 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.033 | 0.069 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.035 CHEMBL1157 | CHEMBL1157 | |
| 0.015 | 0.051 | 0.029 | Retinoic acid gamma receptor agonist | 0.029 0.007 CHEMBL1157 | CHEMBL1157 | |
| 0.027 | 0.064 | 0.061 | Retinoic acid alpha receptor agonist | 0.061 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.068 | 0.047 | Microtubule stabilization | 0.047 0.031 CHEMBL1157 | CHEMBL1157 | |
| 0.012 | 0.05 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.068 | 0.058 | Vanilloid 3 antagonist | 0.058 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.009 | 0.048 | 0.025 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.025 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.068 | 0.049 | Aggrecanase 1 inhibitor | 0.049 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.034 | 0.074 | 0.065 | Carnitine palmitoyltransferase 1B inhibitor | 0.065 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.007 | 0.049 | 0.023 | Endothelin B receptor antagonist | 0.023 0.011 CHEMBL1157 | CHEMBL1157 | |
| 0.054 | 0.095 | 0.067 | Calcium channel P-type blocker | 0.067 0.035 CHEMBL1157 | CHEMBL1157 | |
| 0.069 | 0.111 | 0.218 | Uric acid excretion stimulant | 0.218 0.011 CHEMBL1157 | CHEMBL1157 | |
| 0.023 | 0.066 | 0.031 | Melatonin receptor 1A agonist | 0.031 0.029 CHEMBL1157 | CHEMBL1157 | |
| 0.014 | 0.057 | 0.045 | Endothelin receptor antagonist | 0.045 0.011 CHEMBL1157 | CHEMBL1157 | |
| 0.02 | 0.064 | 0.027 | Glucosylceramidase stimulant | 0.027 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.01 | 0.053 | 0.025 | Endothelin A receptor antagonist | 0.025 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.035 | 0.079 | 0.104 | HIV-1 integrase (Strand Transfer) inhibitor | 0.104 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.025 | 0.071 | 0.051 | Oleamide hydrolase inhibitor | 0.051 0.027 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.069 | 0.045 | Inosine monophosphate dehydrogenase inhibitor | 0.045 0.018 CHEMBL1157 | CHEMBL1157 | |
| 0.041 | 0.088 | 0.074 | Dihydroorotate oxidase inhibitor | 0.074 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.018 | 0.066 | 0.039 | Cholesterol ester transfer protein antagonist | 0.039 0.014 CHEMBL1157 | CHEMBL1157 | |
| 0.041 | 0.09 | 0.1 | HIV-1 integrase (3'-Processing) inhibitor | 0.1 0.026 CHEMBL1157 | CHEMBL1157 | |
| 0.018 | 0.067 | 0.063 | G protein-coupled receptor agonist | 0.063 0.012 CHEMBL1157 | CHEMBL1157 | |
| 0.022 | 0.071 | 0.049 | RNA-directed RNA polymerase inhibitor | 0.049 0.013 CHEMBL1157 | CHEMBL1157 | |
| 0.066 | 0.117 | 0.088 | mTOR complex 2 inhibitor | 0.088 0.051 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.08 | 0.192 | Prostaglandin E2 antagonist | 0.192 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.006 | 0.057 | 0.064 | Prostaglandin EP1 antagonist | 0.064 0.005 CHEMBL1157 | CHEMBL1157 | |
| 0.066 | 0.118 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.042 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.073 | 0.038 | Elastase 2B inhibitor | 0.038 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.073 | 0.038 | Elastase 3A inhibitor | 0.038 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.021 | 0.073 | 0.038 | Elastase 3B inhibitor | 0.038 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.034 | 0.091 | 0.07 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.07 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.037 | 0.095 | 0.065 | Fatty acid synthase inhibitor | 0.065 0.03 CHEMBL1157 | CHEMBL1157 | |
| 0.024 | 0.082 | 0.045 | MAP3K5 inhibitor | 0.045 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.036 | 0.094 | 0.08 | Androgen agonist | 0.08 0.024 CHEMBL1157 | CHEMBL1157 | |
| 0.11 | 0.169 | 0.159 | Tumour necrosis factor antagonist | 0.159 0.09 CHEMBL1157 | CHEMBL1157 | |
| 0.032 | 0.093 | 0.044 | Benzodiazepine antagonist | 0.044 0.043 CHEMBL1157 | CHEMBL1157 | |
| 0.024 | 0.087 | 0.043 | Potassium channel Kv1.3 blocker | 0.043 0.038 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.094 | 0.052 | Cholesterol esterase inhibitor | 0.052 0.027 CHEMBL1157 | CHEMBL1157 | |
| 0.051 | 0.115 | 0.067 | Adenosine A3 receptor antagonist | 0.067 0.064 CHEMBL1157 | CHEMBL1157 | |
| 0.012 | 0.077 | 0.031 | Retinoic acid receptor agonist | 0.031 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.01 | 0.077 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.026 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.025 | 0.092 | 0.07 | Xanthine dehydrogenase inhibitor | 0.07 0.031 CHEMBL1157 | CHEMBL1157 | |
| 0.011 | 0.078 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 CHEMBL1157 | CHEMBL1157 | |
| 0.048 | 0.116 | 0.066 | Secretase beta inhibitor | 0.066 0.057 CHEMBL1157 | CHEMBL1157 | |
| 0.056 | 0.126 | 0.086 | Estrogen receptor alpha antagonist | 0.086 0.041 CHEMBL1157 | CHEMBL1157 | |
| 0.025 | 0.095 | 0.055 | Dihydroorotase inhibitor | 0.055 0.02 CHEMBL1157 | CHEMBL1157 | |
| 0.008 | 0.078 | 0.022 | Retinoic acid receptor antagonist | 0.022 0.01 CHEMBL1157 | CHEMBL1157 | |
| 0.008 | 0.079 | 0.025 | Retinoic acid alpha receptor antagonist | 0.025 0.009 CHEMBL1157 | CHEMBL1157 | |
| 0.04 | 0.113 | 0.112 | Elastase 1 inhibitor | 0.112 0.015 CHEMBL1157 | CHEMBL1157 | |
| 0.067 | 0.142 | 0.097 | T cell inhibitor | 0.097 0.027 CHEMBL1157 | CHEMBL1157 | |
| 0.013 | 0.088 | 0.024 | Sodium/glucose cotransporter inhibitor | 0.024 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.056 | 0.131 | 0.094 | Bronchodilator | 0.094 0.071 CHEMBL1157 | CHEMBL1157 | |
| 0.099 | 0.176 | 0.237 | Pyruvate kinase inhibitor | 0.237 0.065 CHEMBL1157 | CHEMBL1157 | |
| 0.054 | 0.132 | 0.189 | 5-Lipoxygenase inhibitor | 0.189 0.027 CHEMBL1157 | CHEMBL1157 | |
| 0.029 | 0.111 | 0.057 | Aldosterone antagonist | 0.057 0.022 CHEMBL1157 | CHEMBL1157 | |
| 0.011 | 0.093 | 0.037 | HCV NS5B polymerase inhibitor | 0.037 0.016 CHEMBL1157 | CHEMBL1157 | |
| 0.014 | 0.098 | 0.032 | Catechol O-methyltransferase inhibitor | 0.032 0.023 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.12 | 0.054 | CXC chemokine 1 receptor antagonist | 0.054 0.03 CHEMBL1157 | CHEMBL1157 | |
| 0.102 | 0.198 | 0.124 | MAP kinase 3 inhibitor | 0.124 0.123 CHEMBL1157 | CHEMBL1157 | |
| 0.073 | 0.17 | 0.113 | Alkaline phosphatase inhibitor | 0.113 0.096 CHEMBL1157 | CHEMBL1157 | |
| 0.059 | 0.166 | 0.089 | Thioredoxin reductase inhibitor | 0.089 0.042 CHEMBL1157 | CHEMBL1157 | |
| 0.019 | 0.128 | 0.041 | Liver X receptor alpha agonist | 0.041 0.028 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.139 | 0.07 | Lipase inhibitor | 0.07 0.054 CHEMBL1157 | CHEMBL1157 | |
| 0.031 | 0.149 | 0.055 | Nicotinic alpha3beta2 receptor antagonist | 0.055 0.034 CHEMBL1157 | CHEMBL1157 | |
| 0.081 | 0.201 | 0.282 | Dual specificity phosphatase 3 inhibitor | 0.282 0.032 CHEMBL1157 | CHEMBL1157 | |
| 0.011 | 0.131 | 0.026 | Liver X receptor alpha antagonist | 0.026 0.025 CHEMBL1157 | CHEMBL1157 | |
| 0.128 | 0.259 | 0.236 | Hypoxia-inducible factor 1 alpha inhibitor | 0.236 0.113 CHEMBL1157 | CHEMBL1157 | |
| 0.039 | 0.172 | 0.071 | Potassium channel (Tandem pore domain) blocker | 0.071 0.059 CHEMBL1157 | CHEMBL1157 | |
| 0.026 | 0.16 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.035 CHEMBL1157 | CHEMBL1157 | |
| 0.091 | 0.227 | 0.159 | P-glycoprotein inhibitor | 0.159 0.103 CHEMBL1157 | CHEMBL1157 | |
| 0.027 | 0.164 | 0.05 | Potassium channel (Inward rectifier) activator | 0.05 0.036 CHEMBL1157 | CHEMBL1157 | |
| 0.122 | 0.259 | 0.25 | 12-Lipoxygenase inhibitor | 0.25 0.109 CHEMBL1157 | CHEMBL1157 | |
| 0.115 | 0.257 | 0.243 | Thyroid hormone antagonist | 0.243 0.128 CHEMBL1157 | CHEMBL1157 | |
| 0.008 | 0.157 | 0.02 | Elastase 2 inhibitor | 0.02 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.008 | 0.157 | 0.02 | Elastase 2A inhibitor | 0.02 0.017 CHEMBL1157 | CHEMBL1157 | |
| 0.055 | 0.21 | 0.147 | M17 leucyl aminopeptidase inhibitor | 0.147 0.057 CHEMBL1157 | CHEMBL1157 | |
| 0.052 | 0.209 | 0.097 | Beta glucuronidase inhibitor | 0.097 0.075 CHEMBL1157 | CHEMBL1157 | |
| 0.119 | 0.279 | 0.236 | Calpain 2 inhibitor | 0.236 0.16 CHEMBL1157 | CHEMBL1157 | |
| 0.025 | 0.187 | 0.048 | Glucose-6-phosphate translocase inhibitor | 0.048 0.043 CHEMBL1157 | CHEMBL1157 | |
| 0.03 | 0.193 | 0.094 | Androgen antagonist | 0.094 0.051 CHEMBL1157 | CHEMBL1157 | |
| 0.02 | 0.184 | 0.084 | Prostaglandin-E synthase inhibitor | 0.084 0.036 CHEMBL1157 | CHEMBL1157 | |
| 0.056 | 0.244 | 0.114 | Estrogen antagonist | 0.114 0.066 CHEMBL1157 | CHEMBL1157 | |
| 0.056 | 0.245 | 0.108 | Electron transport complex I inhibitor | 0.108 0.066 CHEMBL1157 | CHEMBL1157 | |
| 0.098 | 0.298 | 0.216 | Thyroid hormone beta antagonist | 0.216 0.142 CHEMBL1157 | CHEMBL1157 | |
| 0.081 | 0.285 | 0.15 | 3C-like protease (Human coronavirus) inhibitor | 0.15 0.101 CHEMBL1157 | CHEMBL1157 | |
| 0.023 | 0.242 | 0.073 | Autotaxin inhibitor | 0.073 0.021 CHEMBL1157 | CHEMBL1157 | |
| 0.066 | 0.302 | 0.171 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.171 0.12 CHEMBL1157 | CHEMBL1157 | |
| 0.042 | 0.29 | 0.116 | Cytidine deaminase inhibitor | 0.116 0.105 CHEMBL1157 | CHEMBL1157 | |
| 0.022 | 0.272 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.044 CHEMBL1157 | CHEMBL1157 | |
| 0.081 | 0.419 | 0.253 | Antiobesity | 0.253 0.154 CHEMBL1157 | CHEMBL1157 | |
| 0.027 | 0.373 | 0.118 | Cyclooxygenase 1 inhibitor | 0.118 0.082 CHEMBL1157 | CHEMBL1157 | |
| 0.054 | 0.404 | 0.163 | NOS3 expression enhancer | 0.163 0.061 CHEMBL1157 | CHEMBL1157 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |